Skip to main content

Constellation Pharmaceuticals Inc

CNSTDelisted Jul 15, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0001434418

Constellation Pharmaceuticals Inc was delisted on Jul 15, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 153 institutions reported holding it in 13F filings for Q2 2021, worth $1.48B in total; no superinvestor held it.

Holders of 5% or more of CNST

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Constellation Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Constellation Pharmaceuticals Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

9 Schedule 13D and 13G filings on Constellation Pharmaceuticals Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CNST
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 16, 2021Third Rock Ventures LP13G/AOld format–––SEC
Feb 16, 2021Bain Capital Life Sciences Fund, L.P.13G/AOld format–––SEC
Feb 16, 2021Column Group L P13G/AOld format–––SEC
Feb 16, 2021Great Point Partners LLC13G/AOld format–––SEC
Feb 16, 2021Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 12, 2021Avoro Capital Advisors LLC13G/AOld format–––SEC
Feb 4, 2021Wellington Management Group LLP13GOld format–New–SEC
Feb 2, 20213:13 PM ETBlackRock Inc.13GOld format–New–SEC
Feb 1, 2021Regents of the University of California13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Constellation Pharmaceuticals Inc shares.

No Form 144 notices for Constellation Pharmaceuticals Inc are on file.